Loading company…
SicaGene researches and develops antisense oligonucleotide therapeutics.
Its technologies include platforms for sequence screening, nucleic acid modification and tissue targeting. Its work addresses areas including central nervous system disorders, eye and liver diseases, and viral infections. Founded in 2021, the company is based in Beijing, China. In February 2025, it raised venture funding from Beijing Baiyang Zhongxin Kangjian Investment Management.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in